October 18, 2012 ·
Leave a comment
October 18, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement focused on medical centers of excellence in obesity with a top U. S. biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating the condition of obesity, approached Thought Leader Select for support with a variety of collaborative efforts, including medical science liaison outreach to leading universities, medical schools, teaching hospitals, and specialty clinics in this area. Having already worked with Thought Leader Select to form rosters of key opinion leaders in endocrinology, primary care, nursing, pharmacy, and long-term care in the treatment of type I and type II diabetes and obesity, the company has now chosen Thought Leader Select to pinpoint the leading centers of excellence in the treatment of obesity in the United States.
Known for the versatility of applications for its in-house research and analysis, Thought Leader Select’s research group will assess the skills and experience of selected centers, detailing the collaborative activities of leading physicians and other health care professionals, including registered nurses, physician assistants, nurse practitioners, clinical pharmacists, and medical researchers, the people who advance the science of medicine and patient care, through basic and clinical research, scientific journal ... read more »
TAGS: 
basic research biopharmaceutical industry biotechnology Brian Castle centers of excellence identification centers of excellence profiling centers of excellence strategy clinical pharmacists clinical research drug development endocrinology health care professionals key opinion leaders KOL identification KOL profiling KOL strategy long-term care medical device industry medical diagnostics medical researchers medical schools medical science medical science liaison outreach nursing obesity obesity centers of excellence obesity KOLs patient care pharmaceuticals pharmacy physician assistants physicians primary care medicine registered nurses scientific journal publishing specialty medical clinics teaching hospitals Thought Leader Select Thought Leader Select consulting group Thought Leader Select research group treatment guidelines type 1 diatbetes type 2 diabetes universities
March 14, 2012 ·
Leave a comment
Industry Insights from Brian Castle
As in nearly all other aspects of life, social media is fast becoming a dominant force in the world of healthcare. Leading centers of excellence—hospitals, clinics, research foundations, and universities—are utilizing social media to educate patients about medical resources and treatments on a daily basis. Biopharmaceutical companies are using social media to promote new medications and further educate patients about other wellness resources at their disposal to help with debilitating diseases and conditions.
Physicians and other healthcare professionals, like practically every other profession, are embracing social media at unprecedented levels, engaging with each other on everything from new medical devices to tough medical cases. Due to this rise in HCP use of social media, some have begun to question the very essence of what makes a key opinion leader in the medical profession.
Some of these questioners have gone a step farther, at their ultimate peril, in misinterpreting physician involvement in spaces like Twitter, Facebook, LinkedIn and physician-only social media networks like Sermo. They incorrectly perceive that social media participation is the new thought leadership. Last year, I sat in the audience for a presentation by a leader in the pharmaceutical industry. This person posited a talking point she’d heard from an executive at a physician-only social media network: “If you’re not in their social network, you’re not ... read more »
TAGS: basic research biopharmaceutical companies biotechnology Brian Castle centers of excellence clinical research diseases Facebook global KOL HCPs health care professionals healthcare hospitals key opinion leaders KOL engagement KOL identification KOLs LinkedIn local KOL medical clinics medical conditions medical congresses medical devices medical diagnostics medical meetings medical resources medical treatment options medications national KOL patient education pharmaceuticals physician-only social networks physicians public health regional KOL research foundations scientific journal publishing Sermo social media thought leader engagement thought leader identification Thought Leader Select thought leaders thought leadership treatment guidelines Twitter universities wellness
June 17, 2010 ·
Leave a comment
Industry Insights from Paul Meade, M. Sc, MPH
A recent decision by the Accreditation Council for Continuing Medical Education to not allow scientists employed by pharmaceutical, diagnostics, and devices companies to give educational presentations to physicians at medical meetings has “stirred up a bee’s nest.” In other words, if you graduated from an accredited university, conducted sound research within academia for several years, then joined a pharmaceutical company to carry on your research and were invited to a scientific congress to present your research findings to physicians, you are now being banned to do so because your work might be tainted and biased by your employer. Instead of addressing concerns of biased reporting or misrepresentation of the facts, the ACCME has decided to “throw the baby out with the bath water.”
I have known brilliant scientists who have spent their lifetimes conducting impeccable research within the halls of academia, only to be asked to come into the private sector to complete their research. Is the ACCME now saying those dedicated individuals have “sold their souls to the devil” and suddenly lost all integrity and objectivity? Have there never been researchers within academia that have falsified their data for personal gain and been exposed to the public? Should we ban all researchers in academic centers from presenting their research to physicians at ... read more »
TAGS: academia ACCME Accreditation Councile for Continuing Medical Education bioethics biotechnology continuing medical education ethics medical ethics medical researchers pharmaceutical physicians research findings scientific congress scientists transparency universities
